198 related articles for article (PubMed ID: 37416763)
21. Long non-coding RNA MIR503HG inhibits the proliferation, migration and invasion of colon cancer cells via miR-107/Par4 axis.
Han H; Li H; Zhou J
Exp Cell Res; 2020 Oct; 395(2):112205. PubMed ID: 32738347
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
23. LncCCLM inhibits lymphatic metastasis of cervical cancer by promoting STAU1-mediated IGF-1 mRNA degradation.
Chen C; Shen N; Chen Y; Jiang P; Sun W; Wang Q; Wang Z; Jiang Y; Cheng W; Fu S; Wang S
Cancer Lett; 2021 Oct; 518():169-179. PubMed ID: 34273467
[TBL] [Abstract][Full Text] [Related]
24. LncRNA MIR503HG regulated cell viability, metastasis and apoptosis of cervical cancer via miR-191/CEBPB axis.
Hu YL; Zhang YX; Liu N; Liu H; Yuan YC
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3200-3210. PubMed ID: 33928605
[TBL] [Abstract][Full Text] [Related]
25. c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Chang TM; Chu PY; Hung WC; Shan YS; Lin HY; Huang KW; Chang JS; Chen LT; Tsai HJ
Cancer Sci; 2021 Jan; 112(1):243-253. PubMed ID: 33128283
[TBL] [Abstract][Full Text] [Related]
26. High expression of the long non-coding RNA HEIRCC promotes Renal Cell Carcinoma metastasis by inducing epithelial-mesenchymal transition.
Xiong J; Liu Y; Luo S; Jiang L; Zeng Y; Chen Z; Shi X; Lv B; Tang W
Oncotarget; 2017 Jan; 8(4):6555-6563. PubMed ID: 28030807
[TBL] [Abstract][Full Text] [Related]
27. LncRNA MIR503HG is downregulated in Han Chinese with colorectal cancer and inhibits cell migration and invasion mediated by TGF-β2.
Chuo D; Liu F; Chen Y; Yin M
Gene; 2019 Sep; 713():143960. PubMed ID: 31278965
[TBL] [Abstract][Full Text] [Related]
28. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer.
Song J; Chen W; Cui X; Huang Z; Wen D; Yang Y; Yu W; Cui L; Liu CY
Theranostics; 2020; 10(5):2327-2341. PubMed ID: 32089745
[TBL] [Abstract][Full Text] [Related]
29. Facilitating colorectal cancer cell metastasis by targeted binding of long non-coding RNA ENSG00000231881 with miR-133b via VEGFC signaling pathway.
Zhou J; Zou Y; Hu G; Lin C; Guo Y; Gao K; Wu M
Biochem Biophys Res Commun; 2019 Jan; 509(1):1-7. PubMed ID: 30581003
[TBL] [Abstract][Full Text] [Related]
30. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
Luo Q; Cui M; Deng Q; Liu J
Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
[TBL] [Abstract][Full Text] [Related]
33. In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma.
Yang M; Hlady RA; Zhou D; Ho TH; Robertson KD
Cancer Med; 2019 Sep; 8(12):5760-5768. PubMed ID: 31361072
[TBL] [Abstract][Full Text] [Related]
34. LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment.
Chen C; He W; Huang J; Wang B; Li H; Cai Q; Su F; Bi J; Liu H; Zhang B; Jiang N; Zhong G; Zhao Y; Dong W; Lin T
Nat Commun; 2018 Sep; 9(1):3826. PubMed ID: 30237493
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma.
Liu Y; Gou X; Wei Z; Yu H; Zhou X; Li X
Aging (Albany NY); 2020 Jul; 12(15):15359-15373. PubMed ID: 32716909
[TBL] [Abstract][Full Text] [Related]
36. OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGF‑C expression and secretion.
Ma C; Xie J; Luo C; Yin H; Li R; Wang X; Xiong W; Zhang T; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
Int J Oncol; 2019 Feb; 54(2):572-584. PubMed ID: 30483757
[TBL] [Abstract][Full Text] [Related]
37. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
Li Z; Tang Y; Xing W; Dong W; Wang Z
Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA GClnc1 knockdown suppresses progression of epithelial ovarian cancer by recruiting FOXC2 to disrupt the NOTCH1/NF-κB/Snail pathway.
Wu D; Ke Y; Xiao R; Liu J; Li Q; Wang Y
Exp Cell Res; 2021 Feb; 399(1):112422. PubMed ID: 33338479
[TBL] [Abstract][Full Text] [Related]
39. Survivin gene expression increases gastric cancer cell lymphatic metastasis by upregulating vascular endothelial growth factor-C expression levels.
Zhang J; Zhu Z; Sun Z; Sun X; Wang Z; Xu H
Mol Med Rep; 2014 Feb; 9(2):600-6. PubMed ID: 24337012
[TBL] [Abstract][Full Text] [Related]
40. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.
Liang Y; Chen X; Wu Y; Li J; Zhang S; Wang K; Guan X; Yang K; Bai Y
Cell Death Differ; 2018 Nov; 25(11):1980-1995. PubMed ID: 29511340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
